CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 277

Industry reads hand-picked by our editors

Jan 10, 2018

Gizmodo
Biotech stocks drop after troubling CRISPR study, but gene editing is still the future
PRI
Cuba has a lung cancer vaccine. Many US patients can’t get it without breaking the law.
Science Daily
In urban streams, pharmaceutical pollution is driving microbial resistance

Jan 09, 2018

Bloomberg
How Allergan continues to make drug prices insane
CNBC
Biotech and pharma firms like the tax law — but not because of their new rates
Forbes
Mother alleges biotech firm stole data from her sick children

Jan 08, 2018

The Boston Globe
The year in biotech begins flush with cash
Financial Times
UK in push to remain part of EU medicines agency after Brexit
Reuters
Regeneron forms consortium to accelerate gene sequencing project
TheStreet
America's opioid crisis looks a lot like big tobacco spats of yesteryear

Jan 05, 2018

Medical Marketing & Media
Should pharma fear ICER?
Forbes
Snow, skiing, and a biotech VC's outlook for 2018
Financial Times
Governments and industry must do more on NCDs

Jan 04, 2018

Regulatory Focus
FDA targets multiple review cycles with new draft guidance, MAPP
Life Science Leader
Me-too drug sales return via competitive pricing or marketing
Newsweek
A cure for HIV? Cancer-killing immunotherapy could also fight the virus

Jan 03, 2018

Bloomberg Gadfly
Trump FDA Chief Scott Gottlieb isn't pharma's BFF after all
The Wall Street Journal
This biotech-turned-blockchain company was the hottest Nasdaq stock since 6000
Forbes
Antibiotics are money-losers for big pharma. How can we incentivize the development of new ones?

Jan 02, 2018

The Washington Post
Want to cut health-care costs? Start with the obscene amount of waste.
NPR
Researchers gather health data for 'All of Us'
Forbes
Paris beckons to U.S. biotech investors
Undark
The vexing asymmetry of consumer genetic testing

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Webinar - on demand
Navigating the Impact of Claims Data Volatility on Biopharma Custom content for McKesson Compile
Infographic
Cutting Through the Chaos of Safety Letter Distribution Custom content for WCG
Playbook
How To Make the Most of Your Life Science Webinars Custom content for Cvent

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
AI-Powered Biomarker Discovery: From Screening to Translational Insights Webinar - on demand • Provided by Danaher

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.